Skip to main content
. Author manuscript; available in PMC: 2011 Dec 1.
Published in final edited form as: Clin Pharmacol Ther. 2010 Oct 27;88(6):854–861. doi: 10.1038/clpt.2010.212

Figure 1. Gene expression changes that discriminate treatment outcome.

Figure 1

(A) Expression changes of the six most discriminating genes by linear discriminant analysis (LDA) in patients who remained in complete remission (n =11) and in patients who relapsed (n = 5). (B) Principal component analysis (PCA) plot of 16 patients who received LDMTX/MP, using the six most significant genes predictive of relapse (P = 0.028). (C) Event-free survival curves estimated by Kaplan-Meier analysis.